Health Condition 1: O111- -2146826259 Health Condition 2: O140- Mild to moderate pre-eclampsia
Conditions
Interventions
Intervention1: Mulmina Amla Orange ready to drink: Dose: 200ml drink
Dosage form: Oral
Drink Frequency : 2 packs per day for 4 weeks
Route of administrate : Orally
Total duration: Day 45
Control Inte
Sponsors
Jagdale industries pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1.Female volunteer aged more than 18 to 45 years 2.If pregnant, should have completed 1st trimester of the pregnancy 3.Pregnant Woman At High Risk For Preeclamsia 4.Willing to give written consent to participate
Exclusion criteria
Exclusion criteria: 1.Patients with preexisting severe systemic disease necessitating long term medication. 2.Patients with known history of diabetes mellitus. 3.Evidence of significant uncontrolled co morbid disease which in the investigators opinion would jeopardize patient participation. 4.History of cancer including solid tumors hematologic malignancies and carcinoma in situ 5.Any neurological congenital or acquired vascular or systemic disorder which could affect any of the efficacy assessments. 6.Participation in the current or previous treatment with any approved or investigational health supplements during the past one month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| i. Basic Hematology and Biochemistry (TSH profile, LFT, RFT, Lipid profile) ii. Serum immune markers Cohort 1 (IgE, IgD, SOD, TAC) Cohort 2 (EREG, PDGF-D, Folic Acid, Cortisol, TAC, SOD, IgE, IgD, IL-6, IL-10, PGE-2), iii. Urine analysis - Urine pregnancy test Timepoint: Day 0, 14 and 28 | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessing the overall health of pregnant womenTimepoint: Day 0 to Day 28 | — |
Countries
India
Contacts
Public ContactMr Raghavendra K V
Radiant Research Services Pvt. Ltd
Outcome results
None listed